| Host: |
HEK293 |
| Note: |
STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Recombinant-Human HSP47-protein was developed from hek293. For use in research applications. |
| Conjugation: |
Unconjugated |
| Formulation: |
Lyophilised from 0.2 Mu m filtered PBS solution, pH7.2, 5% Trehalose. |
| Dilution Range: |
Spin the vial and reconstite in distilled water to a concentration not less than 0.1 mg/mL. This can then be diluted into other buffers. |
| Storage Instruction: |
Can be stored in working aliquots at 2°C-8°C C for one month, or at-20°C to-70°C for 1 year. Avoid repeated freeze/thaw cycles. NA |
| Endotoxin: |
Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than 0.1 ng/µg (1EU/µg). NA |
| Gene Symbol: |
SERPINH1 |
| Gene ID: |
871 |
| Uniprot ID: |
SERPH_HUMAN |
| Immunogen Region: |
ALA19-LEU418 |
| Immunogen: |
Optimized DNA sequence encodingHuman heat shock protein-HSP47/SERPINH1 (ALA19-LEU418) extracellular domain including a C-terminal His tag was expressed in HEK293 cells. NA |
| Function | Binds specifically to collagen. Could be involved as a chaperone in the biosynthetic pathway of collagen. |
| Protein Name | Serpin H147 Kda Heat Shock ProteinArsenic-Transactivated Protein 3Astp3Cell Proliferation-Inducing Gene 14 ProteinCollagen-Binding ProteinColliginRheumatoid Arthritis-Related Antigen Ra-A47 |
| Database Links | Reactome: R-HSA-1650814 |
| Cellular Localisation | Endoplasmic Reticulum Lumen |
| Alternative Protein Names | Serpin H1 protein47 Kda Heat Shock Protein proteinArsenic-Transactivated Protein 3 proteinAstp3 proteinCell Proliferation-Inducing Gene 14 Protein proteinCollagen-Binding Protein proteinColligin proteinRheumatoid Arthritis-Related Antigen Ra-A47 proteinSERPINH1 proteinCBP1 proteinCBP2 proteinHSP47 proteinSERPINH2 proteinPIG14 protein |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
